Search results for fatty liver

“Non-alcoholic fatty liver disease (NAFLD), now usually termed metabolic dysfunction-associated steatotic liver disease (MASLD), affects about one in four people worldwide and can progress to serious liver injury and even liver cancer.”

“Using data from more than 2,300 adults, GrimAge accurately predicted time-to-death, time-to-coronary heart disease, time-to-cancer, and age-at-menopause and closely aligned with computed tomography data for fatty liver disease and excess visceral fat.”

“Metabolic dysfunction-associated steatohepatitis (MASH) is a form of fatty liver disease that promotes inflammation and damage over time. Closely connected to conditions like obesity and insulin resistance, MASH affects nearly one-third of people worldwide.”

“Furthermore, SIRT1 can also promote the degradation of PER2, a protein that regulates circadian rhythms of metabolism, locomotor activity, and behavior. In the liver, SIRT1 modulates the circadian expression of acetyl-CoA synthetase 1, an enzyme that controls fatty acid elongation by producing acetyl-CoA.”

“Metabolic dysfunction Increased intestinal permeability is a feature of metabolic diseases such as obesity, non-alcoholic fatty liver disease, type 2 diabetes, and cardiovascular disease.”

“AgeAccelGrim showed strong associations with time-to-death, coronary heart disease, cancer, fatty liver, visceral fat, age at menopause, and comorbidity count. DNAm PAI-1 was especially strongly linked to lifespan, type 2 diabetes, and comorbidity.”

“Other cell culture studies demonstrate that berberine may provide protection against non-alcoholic fatty liver disease, or NAFLD, a syndrome that encompasses multiple states of liver dysfunction, including steatosis, nonalcoholic steatohepatitis, and cirrhosis.”

“These are distinct but connected systems. Brain insulin signaling participates in appetite and energy regulation, while visceral fat can deliver fatty acids and inflammatory signals toward the liver.”

“Butyrate participates in a wide array of metabolic pathways in the body. Accordingly, low concentrations of butyrate in the blood, colon, liver, and brain have been identified in various diseases. Generally, increasing butyrate levels benefits health.”

“The SCN, in turn, coordinates the body's peripheral clocks, such as those found in the liver, pancreas, muscles, and fatty tissue. Consequently, the master clock drives rhythms of rest and activity that determine eating-fasting cycles.”